Published in J Neuroinflammation on January 16, 2012
The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products. Drug Metab Rev (2013) 1.26
A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease. Cell Rep (2012) 1.22
Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. J Neuroimmune Pharmacol (2013) 1.16
Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease. J Neurosci (2012) 1.00
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury. J Neurotrauma (2013) 0.97
Endocannabinoids in nervous system health and disease: the big picture in a nutshell. Philos Trans R Soc Lond B Biol Sci (2012) 0.96
The endocannabinoid system in normal and pathological brain ageing. Philos Trans R Soc Lond B Biol Sci (2012) 0.90
Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging. J Neuroinflammation (2014) 0.85
Orchestrated activation of mGluR5 and CB1 promotes neuroprotection. Mol Brain (2016) 0.84
The influence of cannabinoids on generic traits of neurodegeneration. Br J Pharmacol (2014) 0.84
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation. PLoS One (2015) 0.81
Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment. Mol Psychiatry (2015) 0.81
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications. Neurotherapeutics (2015) 0.81
Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice. Br J Pharmacol (2014) 0.80
WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture. PLoS One (2015) 0.79
Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta. J Neuroinflammation (2016) 0.79
Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection. Mol Neurodegener (2015) 0.79
Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis. J Cell Mol Med (2013) 0.78
CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease. Mol Med (2014) 0.78
Icariin ameliorates neuropathological changes, TGF-β1 accumulation and behavioral deficits in a mouse model of cerebral amyloidosis. PLoS One (2014) 0.77
Rhamnetin attenuates cognitive deficit and inhibits hippocampal inflammatory response and oxidative stress in rats with traumatic brain injury. Cent Eur J Immunol (2015) 0.76
CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease. Mol Med (2013) 0.76
REAC technology modifies pathological neuroinflammation and motor behaviour in an Alzheimer's disease mouse model. Sci Rep (2016) 0.75
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target. Front Neurosci (2017) 0.75
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's Disease. Aging Dis (2015) 0.75
Boosting brain glucose metabolism to fight neurodegeneration? Oncotarget (2017) 0.75
Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists. Front Neurosci (2016) 0.75
CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease. Front Neurosci (2016) 0.75
Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity. J Neuroinflammation (2017) 0.75
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.75
Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science (1996) 19.72
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature (1999) 12.95
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med (2000) 8.89
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev (2002) 8.50
The molecular logic of endocannabinoid signalling. Nat Rev Neurosci (2003) 7.78
Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science (2005) 5.12
Inflammation in neurodegenerative disease--a double-edged sword. Neuron (2002) 4.95
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology (1996) 4.42
APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol (1997) 4.29
Immune activation in brain aging and neurodegeneration: too much or too little? Neuron (2009) 3.76
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging (2005) 3.32
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature (2005) 3.02
Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol (1998) 2.85
Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol (2005) 2.82
Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J Neurosci (1996) 2.69
NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging (1999) 2.41
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci (2005) 2.31
Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain (2005) 2.27
Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation (2006) 2.23
Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med (2002) 2.13
Evidence for novel cannabinoid receptors. Pharmacol Ther (2005) 2.00
Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid. J Neurosci (2003) 1.88
3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg Med Chem (1999) 1.73
Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia (2010) 1.70
Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging (1996) 1.65
A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study. Alzheimer Dis Assoc Disord (2008) 1.63
Cannabinoids and neuroinflammation. Br J Pharmacol (2004) 1.62
Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. J Neurosci (2002) 1.61
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J Neuroinflammation (2005) 1.57
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. Brain (2009) 1.50
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res (2001) 1.49
Cannabinoid signaling in glial cells. Glia (2004) 1.35
Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int J Dev Neurosci (2000) 1.32
Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis (2002) 1.31
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell Mol Life Sci (2006) 1.28
Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain. J Neurochem (2007) 1.26
Acute neuronal injury, excitotoxicity, and the endocannabinoid system. Mol Neurobiol (2002) 1.24
Cannabinoid receptors in microglia of the central nervous system: immune functional relevance. J Leukoc Biol (2005) 1.21
Endocannabinoids and neuroprotection. Sci STKE (2002) 1.20
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. J Neurochem (2004) 1.20
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. Neurosci Lett (2006) 1.13
Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats. Neurobiol Aging (2007) 1.11
Synaptic correlates of increased cognitive vulnerability with aging: peripheral immune challenge and aging interact to disrupt theta-burst late-phase long-term potentiation in hippocampal area CA1. J Neurosci (2010) 1.11
Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. Brain (2011) 1.10
WNT signaling in activated microglia is proinflammatory. Glia (2010) 1.07
Endocannabinoids in cognition and dependence. Prostaglandins Leukot Essent Fatty Acids (2002) 1.07
Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis. Neurobiol Dis (2009) 1.05
Alzheimer's disease; taking the edge off with cannabinoids? Br J Pharmacol (2007) 1.03
Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory. Neurobiol Learn Mem (2008) 1.01
Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons. Hippocampus (2003) 0.99
The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. J Mol Med (Berl) (2005) 0.99
Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression. Br J Pharmacol (2007) 0.98
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease. Mol Pharmacol (2011) 0.96
Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2). Bioorg Med Chem (2010) 0.94
Gene expression as peripheral biomarkers for sporadic Alzheimer's disease. J Alzheimers Dis (2009) 0.94
Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice. J Neuropathol Exp Neurol (2004) 0.94
Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis (2010) 0.93
Early detection of Alzheimer's disease with PET imaging. Neurodegener Dis (2010) 0.90
Endocannabinoid system in the adult rat circumventricular areas: an immunohistochemical study. J Comp Neurol (2010) 0.89
An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease. Neurobiol Aging (2011) 0.88
The endocannabinoid system and Alzheimer's disease. Mol Neurobiol (2007) 0.88
Post-training CB1 cannabinoid receptor agonist activation disrupts long-term consolidation of spatial memories in the hippocampus. Neuroscience (2007) 0.86
Molecular neurobiology of the cannabinoid receptor. Int Rev Neurobiol (1996) 0.85
Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease. J Alzheimers Dis (2007) 0.85
The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis. Vitam Horm (2009) 0.81
Metabolic mapping of the effects of WIN 55212-2 intravenous administration in the rat. Neuropsychopharmacology (1999) 0.81
Application of coregistration for imaging of animal models of epilepsy. Epilepsia (2007) 0.80
Cannabinoid CB1 receptor protein expression in the rat choroid plexus: a possible involvement of cannabinoids in the regulation of cerebrospinal fluid. Neurosci Lett (2004) 0.78
Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer's disease mouse model. Curr Alzheimer Res (2010) 0.78
The CB1 receptor agonist, WIN 55,212-2, dose-dependently disrupts object recognition memory in adult rats. Neurosci Lett (2009) 0.78
Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer. J Clin Oncol (2005) 2.34
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci (2005) 2.31
SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol Cell Biol (2011) 2.08
Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem (2003) 2.06
The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol (2008) 2.03
Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem (2006) 1.82
Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood (2004) 1.47
Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. J Neurosci (2005) 1.40
Megalin mediates the transport of leptin across the blood-CSF barrier. Neurobiol Aging (2007) 1.35
Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Glia (2010) 1.34
Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB. J Neurosci (2004) 1.30
Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis. Mol Cell Biol (2012) 1.28
Ceramide and reactive oxygen species generated by H2O2 induce caspase-3-independent degradation of Akt/protein kinase B. J Biol Chem (2002) 1.26
GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem (2007) 1.24
Role of insulin-like growth factor I signaling in neurodegenerative diseases. J Mol Med (Berl) (2003) 1.22
Leptin regulates glutamate and glucose transporters in hypothalamic astrocytes. J Clin Invest (2012) 1.21
Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death. Mol Cell Neurosci (2008) 1.18
Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J Biol Chem (2003) 1.17
Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Antioxid Redox Signal (2011) 1.17
Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Curr Drug Targets (2010) 1.15
Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. J Neurovirol (2005) 1.14
Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3. Free Radic Biol Med (2011) 1.11
Protein kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivo. FEBS Lett (2004) 1.10
Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease? Neurobiol Aging (2005) 1.09
α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease. Hum Mol Genet (2012) 1.08
Role of microglial redox balance in modulation of neuroinflammation. Curr Opin Neurol (2009) 1.04
Signaling through the leukocyte integrin LFA-1 in T cells induces a transient activation of Rac-1 that is regulated by Vav and PI3K/Akt-1. J Biol Chem (2004) 1.04
Looking at emotional words is not the same as reading emotional words: Behavioral and neural correlates. Psychophysiology (2010) 1.03
Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38-MAPK pathway. Oncogene (2002) 1.02
Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease. J Alzheimers Dis (2011) 1.02
Interleukin-1beta enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase/Akt pathway: relevance to sepsis-associated encephalopathy. J Biol Chem (2006) 1.01
Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor. J Biol Chem (2006) 1.01
Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1. PLoS One (2010) 0.99
Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor. J Cell Sci (2009) 0.99
Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: modulation by the Nrf2/Trx axis. Free Radic Biol Med (2010) 0.98
Nuclear import and export signals control the subcellular localization of Nurr1 protein in response to oxidative stress. J Biol Chem (2013) 0.98
Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor. Bioorg Med Chem Lett (2011) 0.98
Role of serum insulin-like growth factor I in mammalian brain aging. Growth Horm IGF Res (2004) 0.97
Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA. Eur J Neurosci (2008) 0.96
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease. Mol Pharmacol (2011) 0.96
Arousal contributions to affective priming: electrophysiological correlates. Emotion (2009) 0.94
Nordihydroguaiaretic acid activates the antioxidant pathway Nrf2/HO-1 and protects cerebellar granule neurons against oxidative stress. Neurosci Lett (2008) 0.94
A reduction in the amount and anti-contractile effect of periadventitial mesenteric adipose tissue precedes hypertension development in spontaneously hypertensive rats. Hypertens Res (2008) 0.94
Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study. BMC Neurol (2010) 0.93
Pathological alteration in the choroid plexus of Alzheimer's disease: implication for new therapy approaches. Front Pharmacol (2012) 0.91
Deficiency of Nrf2 accelerates the effector phase of arthritis and aggravates joint disease. Antioxid Redox Signal (2011) 0.91
Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease. Neurobiol Dis (2009) 0.91
Computerized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents: the PRESCRIB project. Hepatology (2014) 0.91
Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. Brain (2013) 0.91
The PTEN/NRF2 axis promotes human carcinogenesis. Antioxid Redox Signal (2014) 0.90
Regulation of heme oxygenase-1 gene expression through the phosphatidylinositol 3-kinase/PKC-zeta pathway and Sp1. Free Radic Biol Med (2006) 0.90
Megalin interacts with APP and the intracellular adapter protein FE65 in neurons. Mol Cell Neurosci (2010) 0.90
Redox control of microglial function: molecular mechanisms and functional significance. Antioxid Redox Signal (2014) 0.90
The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease. Biomaterials (2010) 0.89
Abeta accumulation in choroid plexus is associated with mitochondrial-induced apoptosis. Neurobiol Aging (2008) 0.89
Heme oxygenase-1 induction modulates microsomal prostaglandin E synthase-1 expression and prostaglandin E(2) production in osteoarthritic chondrocytes. Biochem Pharmacol (2009) 0.89
Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease. Acta Neuropathol (2009) 0.89
The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection. J Neurochem (2009) 0.88
Beta-amyloid25-35 inhibits glutamate uptake in cultured neurons and astrocytes: modulation of uptake as a survival mechanism. Neurobiol Dis (2004) 0.87
Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice. Eur J Neurosci (2006) 0.87
Electrophysiological differences in the processing of affective information in words and pictures. Cogn Affect Behav Neurosci (2009) 0.87
Valproate suppresses status epilepticus induced by 4-aminopyridine in CA1 hippocampus region. Epilepsia (2003) 0.87
Spleen tyrosine kinase promotes acute neutrophil-mediated glomerular injury via activation of JNK and p38 MAPK in rat nephrotoxic serum nephritis. Lab Invest (2011) 0.86
The purinergic P2Y(13) receptor activates the Nrf2/HO-1 axis and protects against oxidative stress-induced neuronal death. Free Radic Biol Med (2010) 0.86
Changes in molecular isoform distribution of acetylcholinesterase in rat cortex and cerebrospinal fluid after intracerebroventricular administration of amyloid beta-peptide. Neurosci Lett (2002) 0.86
Retracted S-allyl cysteine protects against 6-hydroxydopamine-induced neurotoxicity in the rat striatum: involvement of Nrf2 transcription factor activation and modulation of signaling kinase cascades. Free Radic Biol Med (2012) 0.86
Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors. Eur J Pharmacol (2005) 0.86
6-OHDA-induced apoptosis and mitochondrial dysfunction are mediated by early modulation of intracellular signals and interaction of Nrf2 and NF-κB factors. Toxicology (2012) 0.85
Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease. Neurobiol Aging (2013) 0.85
WNT-3A regulates an Axin1/NRF2 complex that regulates antioxidant metabolism in hepatocytes. Antioxid Redox Signal (2014) 0.85
Synthesis of glycosyl derivatives as dopamine prodrugs: interaction with glucose carrier GLUT-1. Org Biomol Chem (2003) 0.85
Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats. Exp Neurol (2007) 0.84
Insulin-like growth factor I modifies electrophysiological properties of rat brain stem neurons. J Neurophysiol (2003) 0.84
Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum. Glia (2011) 0.84
Syntactic expectancy: an event-related potentials study. Neurosci Lett (2005) 0.84
Gelsolin restores A beta-induced alterations in choroid plexus epithelium. J Biomed Biotechnol (2010) 0.83
Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice. Liver Int (2014) 0.83
Priming effects on the N400 in the affective priming paradigm with facial expressions of emotion. Cogn Affect Behav Neurosci (2013) 0.83
Neurogenic effects of β-amyloid in the choroid plexus epithelial cells in Alzheimer's disease. Cell Mol Life Sci (2013) 0.83
Increased dosage of Ink4/Arf protects against glucose intolerance and insulin resistance associated with aging. Aging Cell (2012) 0.83
Xanthine oxidase-derived extracellular superoxide anions stimulate activator protein 1 activity and hypertrophy in human vascular smooth muscle via c-Jun N-terminal kinase and p38 mitogen-activated protein kinases. J Hypertens (2007) 0.82
PLA2G3, a gene involved in oxidative stress induced death, is associated with Alzheimer's disease. J Alzheimers Dis (2010) 0.82
Higher-order activity beyond the word level: cortical dynamics of simple transitive sentence comprehension. Brain Lang (2005) 0.82
Synthesis and structure-activity relationships of a new model of arylpiperazines. 8. Computational simulation of ligand-receptor interaction of 5-HT(1A)R agonists with selectivity over alpha1-adrenoceptors. J Med Chem (2005) 0.81